On November 1, 2023, the Company’s Board of Directors authorized a share repurchase plan for up to $300,000 in shares of the Company’s common stock, par value $0.001 per share. The share repurchase program is scheduled to expire on November 1, 2028. Repurchases of shares of common stock under the stock repurchase plan will be made in accordance with applicable securities laws and may be made under a variety of methods, which may include open market purchases. The stock repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion.

There were no repurchases of common stock during the six months ended July 3, 2026 and July 4, 2025. As of July 3, 2026, authorized repurchases of $250,000 remain available to the Company.

The following table summarizes the allocation of stock-based compensation in the accompanying condensed consolidated statements of operations:


	For the three months ended				For the six months ended
	July 3, 2026		July 4, 2025		July 3, 2026		July 4, 2025
Cost of sales	$	239	$	347	$	522	$	645
Sales and marketing	389		461		771		850
Research and development	511		395		944		727
General and administrative	2,233		3,359		5,255		5,695
Total	$	3,372	$	4,562	$	7,492	$	7,917

The Company grants both time-based and performance-based stock awards, which also include a time-based vesting feature. Compensation expense for time-based stock awards is measured at the grant date based on the closing market price of the Company’s common stock and recognized ratably over the vesting period.

For performance-based stock awards, compensation expense is measured based on estimates of the number of shares ultimately expected to vest at each reporting date based on management’s expectations regarding the relevant performance criteria. The recognition of compensation expense associated with performance-based stock awards requires defined criteria for assessing achievement and judgment in assessing the probability of meeting the performance goals.

The following table summarizes the activity for the Company’s unvested restricted stock units (“RSUs”) for the six months ended July 3, 2026:


	Unvested RSUs
	Number of shares outstanding	Weighted-average grant date fair value
Unvested at January 2, 2026	746	$	33.95
Granted	652	$	18.03
Canceled	(48)	$	28.18
Vested	(320)	$	38.50
Unvested at July 3, 2026	1,030	$	22.73

As of July 3, 2026, the Company had approximately $19,790 of unrecognized stock-based compensation expense related to RSUs, which will be recognized over the remaining weighted-average vesting period of approximately 1.97 years.

During the six months ended July 3, 2026, the Company issued performance-based restricted stock units (“PSUs”) to certain executives that represent shares potentially issuable in the future. Issuance is based upon the Company’s performance, over a three-year performance period, on certain measures including return on invested capital and free cash flow. The PSUs vest only upon the achievement of the applicable performance goals for the performance period and, depending on the actual achievement on the performance goals, the grantee may earn between 0% and 200% of the target PSUs.


	Unvested PSUs
	Number of shares outstanding	Weighted-average grant date fair value
Unvested at January 2, 2026	464	$	35.03
Granted	595	$	18.03
Canceled	(7)	$	41.60
Vested	—	$	—
Unvested at July 3, 2026	1,052	$	25.38